EDWARD ACQUAH: Open Payments
NPI 1356031751 · BERGENFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,994 in 115 payments from 9 companies in 2025. Trend: 2023 $115 · 2024 $1,389 · 2025 $1,994
Food & beverage: $1,883Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 54 | $872 |
| Teva Pharmaceuticals USA, Inc. | 14 | $296 |
| E.R. Squibb & Sons, L.L.C. | 28 | $294 |
| Alkermes, Inc. | 8 | $239 |
| Otsuka America Pharmaceutical, Inc. | 7 | $226 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: INGREZZA, COBENFY, REXULTI, ARISTADA, UZEDY, LYBALVI, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
